It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

The survey of 1,078 adults, carried out by Ipsos, found 24% of people would use weight-loss jabs if they were provided for ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

However, while Wegovy is prescribed by the NHS for weight management, Rybelsus is not licensed for such and is only available as a treatment for Type 2 diabetes. There are other limitations too. In ...

The new results are from a phase 1 trial of a once-daily pill called CT-966 ... Novo Nordisk's oral formulation of semaglutide for diabetes – Rybelsus – needs to be dosed in the fasting ...

The 50 mg oral semaglutide pill achieved a 15.1% ... Oral semaglutide is already sold as Rybelsus in a 14 mg formulation for the treatment of type 2 diabetes, bringing in sales of $1.6 billion ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

With over 101 million Indians estimated to be suffering from diabetes and another 136 million at the pre-diabetes stage, as per the Indian Council for Medical Research (ICMR), there is an urgent ...

Study estimates 136.8 million U.S. adults are eligible for semaglutide, a popular therapy for diabetes, weight loss, and cardiovascular disease.

The best diabetes medication if you have kidney disease can vary by the severity of your kidney damage. You may need to use one that does not require dose adjustment based on your kidney function.